| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,949.00
|
|
Change (%)
|
5.00 (0.26%)
|
|
Best Buy (RS)
|
1948.4(x17)
|
|
Best Sell (RS)
|
1949(x1)
|
|
Today's Range (RS)
|
1,945.75
-
1,956.95
|
|
52-Week Range (RS)
|
1,547.25
-
2,047.55
|
|
Beta (1 Year)
|
0.46
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Sun Pharmaceutical Industries receives ratings action from CRISIL |
| Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter |
| Sun Pharma Q1 PAT climbs 27% YoY to Rs 2,895 cr; India business drives growth |
| Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessions |
| Sun Pharma receives Organon shareholders approval for merger |
| Sun Pharma receives approval to market semaglutide injection in South Africa |
| Sun Pharma gets nod for Semaglutide injection in South Africa |
| Barometers trade higher; private bank shares jump |
| Sun Pharmaceuticals Industries announces board meeting date |
| Sun Pharmaceutical Industries Ltd spurts 0.07%, up for five straight sessions |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
30-Jul-2026 |
2000.75 |
-2.84 |
| 1Month |
06-Jul-2026 |
1913.05 |
1.62 |
| 3Month |
06-May-2026 |
1850.40 |
5.06 |
| 6Month |
06-Feb-2026 |
1694.70 |
14.71 |
| 1Year |
06-Aug-2025 |
1594.10 |
21.95 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.80 |
3777.97 |
| ICICI Pru Value Fund |
4.79 |
2881.80 |
| SBI BSE SENSEX ETF |
2.21 |
2638.87 |
| ICICI Pru Large Cap Fund |
2.52 |
1997.52 |
| ICICI Pru Equity & Debt Fund |
3.60 |
1854.57 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Cipla Ltd |
1,468.35 |
-0.45 |
1,672.20 |
1,165.55 |
119,157.18 |
| Zydus Lifesciences Ltd |
1,105.50 |
-0.07 |
1,181.00 |
835.85 |
110,348.86 |
| Lupin Ltd |
2,396.75 |
0.22 |
2,530.00 |
1,838.65 |
109,347.16 |
| Mankind Pharma Ltd |
2,431.80 |
0.04 |
2,670.00 |
1,909.90 |
100,395.19 |
| Laurus Labs Ltd |
1,846.10 |
0.55 |
1,858.95 |
810.75 |
99,201.32 |
|
|
|
|